Navigation Links
Verified Clinical Trials (VCT) Will Co-Present With SAFE-BioPharma At Bio-IT World April 10th In Boston, MA Exploring Identity Management In eClinical Trials
Date:4/10/2013

Boston, MA (PRWEB) April 10, 2013

Verified Clinical Trials (VCT) will co-present with SAFE-BioPharma at Bio-IT World April 10th at 4PM in Boston, MA. The session titled “POC Today/ Practical Application Tomorrow: An Inside Look at How Several Companies are Exploring Identity Management in the e-Clinical Trial Space", will focus on innovative proofs of concept for moving clinical trials to fully electronic processes.

Kerri Weingard, ANP, Chief Operating Officer of Verified Clinical Trials and Mollie Shields-Uehling, MA and CEO of SAFE Bio-Pharma Association, will share the way several global companies are utilizing Verified Clinical Trials research subject database and universal identity management protocols (a single cyber-identity recognized by all Sponsors) to improve subject safety, enhance data quality and to maximize use of mobile devices in clinical trials. In a presentation developed in collaboration with Mitchell Efros, MD, President & CEO of Verified Clinical Trials, Kerri will discuss a new capability which leverages the SAFE-BioPharma digital identity and signature standard to provide a mechanism for strong subject identity verification along with the ability to protect those identities for research trial purposes.

This presentation will be held as part of the E-Clinical Trials Solutions, Innovative Management in Clinical Trials track of Bio-IT World. Kerri will be co-presenting with Mollie Shields-Uehling, CEO SAFE-BioPharma, a non profit association which manages the SAFE–BioPharma standard for digital identity and digital signatures used in life science and health care. The session will feature several proof of concepts including the use of tablets to collect patient data in hospital blackout zones, digitally signing ePrescriptions, and managing access to clinical portals. The POCs are designed to decrease study start up time, reduce cost to start up and operation of trial, ensure the security and privacy of subject information and improve safety and data quality.

VCT will issue digital identities based on the SAFE-BioPharma standard for all clinical research site personnel. These personnel may use their SAFE credentials for authentication and signing of documents including signing of 1572, budgets, contract, delegation logs, e-consents, amendments, study protocol signature pages, training modules, and other study related documents. This will result in reduced paperwork, decreased study start up times, decreased cost and assurance of a verified identity.

Clinical trial volunteers will also be verified and obtain SAFE-BioPharma digital identities to ensure true identity. Research subject participants across all studies will be able to issued by a VCT a proxy de-identified digital identity to sign e-consents, e-diaries, and study related information. The research subject participants will be verified to prevent attempted dual enrollment in clinical trials to ensure better quality research subjects enter the trials.

The technologies will also be used to create a map of disease entities by geography and create a research subject self-managed ‘opt-in’ method for pharmaceutical companies to anonymously reach out to subjects directly for study safety updates and for recruitment purposes. In an effort to improve safety, pharmaceutical companies will have the ability to directly reach out to the consenting research subjects that will remain de-identified and anonymous. In this manner, important information regarding the study compound or device such as new safety information, post study safety reporting and creation of on-going registries can be delivered directly to those research subjects wishing to be contacted. Additionally, if so desired, many research subjects will now be able to learn when new clinical trials arise, whether thy received the study medication or placebo, be alerted when the study medication is approved for use and obtain the results of the trial as well by direct anonymous contact by the pharmaceutical company.

About Verified Clinical Trials

Verified Clinical Trials is a forward thinking company developed by experts active in the clinical research community to proactively improve research subject safety and data quality in clinical research trials. Verified Clinical Trials halts dual enrollment in clinical trials and defines itself as the world's leader in the field of database registries in clinical trial research. Verified Clinical Trials is the only clinical research database registry designed specifically to enhance the quality of both early and late phase trials and has the scalability to reach all sites nationally as well as on a global level. Verified Clinical Trials offers numerous other value added services to the clinical research site, CRO, and Pharmaceutical Sponsor, that prove invaluable with regards to safety, data quality, recruitment, financial and legal compliance and liabilities. For more information, visit http://www.verifiedclinicaltrials.com.

Verified Clinical Trials Contact:
Kerri Weingard ANP Chief Operating Officer
Phone: (516) 998-7499
kweingard(at)verifiedclinicaltrials(dot)com

Read the full story at http://www.prweb.com/releases/VerifiedClinicalTrials/SAFEBioPharmabioIT/prweb10618045.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. American Journal of Infection Control Study Validates ATP Testing for Monitoring Sanitation in Hospitals; Charm Sciences Test Verified
2. Research Volunteer Registry from Verified Clinical Trials Adopted by ICON
3. WCCT Global (WCCT) & Verified Clinical Trials (VCT) Announce Medication Adherence Documentation Capabilities Have Been Added to the VCT Clinical Trials Database Registry
4. Verified Clinical Trials Will Exhibit at the Annual 2013 SCOPE Summit to Discuss the Professional Research Subject and the Clinical Trial Database Registry
5. Boulder Canyon Natural Foods Receives Non-GMO Project Verified Seal For Its Kettle-Cooked Chips
6. Nutrex Hawaii to Showcase Non-GMO Project Verified Spirulina Pacifica Superfood at 2013 Natural Products Expo West
7. Clinilabs Launches Research Volunteer Authentication Initiative Choosing Verified Clinical Trials to Stop Dual Enrollment in Clinical Trials
8. ChemoCentryx Presents Positive Results for Novel CCR2 Inhibitor in Preclinical Models of Diabetic Nephropathy at the 44th Annual Meeting of the American Society of Nephrology
9. Positive Clinical Study Results for BSPs HyperQ Technology
10. DermTechs Non-invasive Melanoma Detection Assay Poised to Enter Clinical Validation Study
11. Nile Therapeutics Announces Top-Line Results in Clinical Trial Evaluating the Subcutaneous Infusion of Cenderitide, Meets Primary Endpoint
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2016)...  Allergan plc (NYSE: AGN ) a leading ... , Allergan,s CEO and President, will be featured as ... the RBC Capital Markets Healthcare Conference on Tuesday, February ... York Palace Hotel in New York, NY ... can be accessed on Allergan,s Investor Relations web site ...
(Date:2/10/2016)... ... February 10, 2016 , ... SonaCare Medical, LLC reports ... program, Sonalink™ remote monitoring. The inaugural launch of this new technology occurred over ... Dr. Samuel Peretsman to a HIFU technical expert at SonaCare Medical headquarters. ...
(Date:2/10/2016)... ... February 09, 2016 , ... Creation Technologies, ... of the Highest Overall Customer Rating Award from Circuits Assembly , today announced ... across the USA, Canada, Mexico and China. , The EMS provider, known in ...
(Date:2/9/2016)... ... 2016 , ... Clinovo , the cloud-based eClinical software ... Capture (EDC) system ClinCaptureand its new Contract Research Organization (CRO) Partner Program ... San Mateo, California on February 10th and 11th. Watch 2-min video . ...
Breaking Biology Technology:
(Date:1/25/2016)... , Jan. 25, 2016  Glencoe Software, the world-leading ... and publication industries, will provide the data management solution ... (NPSC). ... Phenotypic analysis measures the ... organisms, allowing comparisons between states such as health and ...
(Date:1/21/2016)... , January 21, 2016 ... to a new market research report "Emotion Detection and ... Others), Software Tools (Facial Expression, Voice Recognition and ... - Global forecast to 2020", published by MarketsandMarkets, ... expected to reach USD 22.65 Billion by 2020, ...
(Date:1/20/2016)... JOSE, Calif. , Jan. 20, 2016 /PRNewswire/ ... developer of human interface solutions, today announced sampling ... controller solution for wearables and small screen applications ... such as printers. Supporting round and rectangular shapes, ... S1423 offers excellent performance with moisture on screen, ...
Breaking Biology News(10 mins):